Workflow
港股新股热潮涌动 医药生物与新能源龙头齐发力
Zhong Guo Xin Wen Wang·2025-05-23 12:51

Group 1 - The Hong Kong stock market has shown active performance from May 19 to May 23, with significant interest and capital inflow in the pharmaceutical and biotechnology sectors [1][2] - On May 23, the Hang Seng Index closed at 23,601.26 points, up 56.95 points or 0.24%, with a total turnover of 203.67 billion HKD for the day [1] - The pharmaceutical sector was a market highlight, particularly with the strong debut of Jiangsu Hengrui Medicine Co., Ltd., which had an IPO price of 44.05 HKD and saw a first-day increase of 25.2% [1][2] Group 2 - Singapore-based biotechnology company Mirae Group Holdings Limited also listed in Hong Kong, closing with a stock price increase of 28.76% and a market capitalization of 8.29 billion HKD [2] - The overall market strength was significantly supported by the listing of CATL (Contemporary Amperex Technology Co., Limited), which opened at 296 HKD and saw a first-day increase of 16%, followed by a further 10% rise the next day, closing at 322.4 HKD with a total market value of 1.47 trillion HKD [2] - The successful listings of industry leaders like CATL and Hengrui Medicine not only inject strong momentum into the Hong Kong stock market but also highlight Hong Kong's attractiveness as an international financial center for global quality enterprises [2]